Erratum
for
Casula et al., J Clin Oncol 22 (2) 286-292.
Journal of Clinical Oncology, Vol 23, No 4 (February 1), 2005: pp. 936
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.11.942
ERRATUM
The January 15, 2004, article by Casula et al entitled, "BRAF Gene Is Somatically Mutated But Does Not Make a Major Contribution to Malignant Melanoma Susceptibility: The Italian Melanoma Intergroup Study" (J Clin Oncol 22:286-292, 2004) contained two errors.
As mutation V599E was confirmed at somatic level only, three was incorrectly inserted in the place of two throughout the manuscript when referring to BRAF germline mutations.
The Q608H mutation was wrongly indicated as G608H mutation throughout the manuscript.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. H Schroder
Early versus delayed endocrine therapy for prostate cancer
Endocr. Relat. Cancer,
March 1, 2007;
14(1):
1 - 11.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. James, T. Dumeni, M. S. Stark, D. L. Duffy, G. W. Montgomery, N. G. Martin, and N. K. Hayward
Rapid Screening of 4000 Individuals for Germ-line Variations in the BRAF Gene
Clin. Chem.,
September 1, 2006;
52(9):
1675 - 1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|